Myriad Genetics
MYGN
MYGN
223 hedge funds and large institutions have $1.35B invested in Myriad Genetics in 2016 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 85 increasing their positions, 71 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
20% less capital invested
Capital invested by funds: $1.7B → $1.35B (-$348M)
74% less call options, than puts
Call options by funds: $5.7M | Put options by funds: $22.1M
Holders
223
Holding in Top 10
1
Calls
$5.7M
Puts
$22.1M
Top Buyers
| 1 | +$67.7M | |
| 2 | +$24.7M | |
| 3 | +$11.1M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$10.1M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$9.65M |
Top Sellers
| 1 | -$75.3M | |
| 2 | -$53M | |
| 3 | -$24.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$15.7M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$14.1M |